Evidence map›Paper›PMID 33027592›Full record

ArticlePharmaceutical biology2020

Aaptamine attenuates the proliferation and progression of non-small cell lung carcinoma.

Kaikai Gong, Shuang Miao, Lijuan Yang, Yan Wu, Jiwei Guo, Weiwei Chen, Juanjuan Dai, Jing Du, Sichuan Xi

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Biological Activity of Naturally Derived Naphthyridines.Molecules (Basel, Switzerland) · 2021
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kaikai GongCancer Research Institute, Binzhou Medical University Hospital, Binzhou, PR China.ORCID https://orcid.org/0000-0003-2575-5533
Shuang MiaoCancer Research Institute, Binzhou Medical University Hospital, Binzhou, PR China.
Lijuan YangCancer Research Institute, Binzhou Medical University Hospital, Binzhou, PR China.
Yan WuCancer Research Institute, Binzhou Medical University Hospital, Binzhou, PR China.
Jiwei GuoCancer Research Institute, Binzhou Medical University Hospital, Binzhou, PR China.
Weiwei ChenCancer Research Institute, Binzhou Medical University Hospital, Binzhou, PR China.
Juanjuan DaiCancer Research Institute, Binzhou Medical University Hospital, Binzhou, PR China.
Jing DuCancer Research Institute, Binzhou Medical University Hospital, Binzhou, PR China.
Sichuan XiCancer Research Institute, Binzhou Medical University Hospital, Binzhou, PR China.
Binzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextAaptamine is a potent ocean-derived non-traditional drug candidate against human cancers. However, the underlying molecular mechanisms governing aaptamine-mediated repression of lung cancer cells remain largely undefined.

objectiveTo examine the inhibitory effect of aaptamine on proliferation and progression of non-small cell lung carcinoma (NSCLC) and dissect the potential mechanisms involved in its anticancer functions. MATERIALS AND

methods

resultsAaptamine significantly inhibited A549 and H1299 cells proliferation with IC DISCUSSION AND

conclusionsAaptamine retarded the proliferation and invasion of NSCLC cells by selectively targeting the pathway PI3K/AKT/GSK3β suggesting it as a potential chemotherapeutic agent for repressing tumorigenesis and progression of NSCLC in humans.

Indexed as

A549 CellsAntineoplastic AgentsCarcinoma, Non-Small-Cell LungCell Line, TumorCell ProliferationDisease ProgressionDose-Response Relationship, DrugGlycogen Synthase Kinase 3 betaHumansInhibitory Concentration 50Lung NeoplasmsNaphthyridinesNeoplasm InvasivenessPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktaaptamineAntineoplastic AgentsGlycogen Synthase Kinase 3 betaGSK3B protein, humanNaphthyridinesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktCDKCylinNSCLCPI3K/AKT/GSK3β pathway

Identifiers

PMID33027592
PMCPMC7580566
OpenAlexW3092258572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.